Took the weekend to revisit and write down my #cannabis thesis.

Company commentary at the bottom. $AYRWF $GTBIF $VRNOF $TCNNF $CRLBF $CURLF

Best ETF: $MSOS

(This post is not investment advice)
TL;dr:

- Cannabis should grow durably over the next 3-5 years
- Several potential catalysts on the come from new states legalizing cannabis to Congressional action (SAFE Banking, decriminalization, legalization)
- Attractive valuations, especially for the growth...
1) According to @NewFrontierData, cannabis is a $80Bn market today, but only $20Bn are legal sales and $60Bn are illicit. Legal sales are estimated to grow to $41.5Bn in 2025 (mid-teens CAGR) assuming no new states legalize in the future, which is very conservative...
2) 35 states + DC have legalized medical sales and 15 states + DC have legalized recreational/adult-use (AU) sales to date. Within these, the limited license states (East Coast, Midwest, and AZ) are the most attractive and should grow faster than the market...
3) Seeing strong momentum in several states for AU legalization. VA is very close (bill on governor's desk) and NY could be close behind. In addition, CT, PA, MD, FL, MN, NM, and others could legalize AU over the next 1-2 years...
4) Why are so many states talking about cannabis? 3 major reasons:

a) States need the tax revenues (especially after COVID)
b) Desire for social justice
c) People want it. Cannabis is drawing support from across the political spectrum...

cnbc.com/2021/03/05/vir…
5) Taken together, the cannabis market is positioned to see sustainable (and as COVID showed us, durable) growth over the next several years, driving revenue/profit growth for the US operators. Importantly, the industry will grow even without movement at the Federal level...
6) Speaking of Congress, there are a couple key catalysts that could manifest over the next 12-18 months. In my mind, the most important is SAFE Banking. I think of "SAFE Banking" addressing 3 components which may or may not all come in the same bill...
7)

a) Access to capital markets (most important for the stocks). Would allow MSOs to up-list on major US exchanges, greatly increasing the visibility and liquidity of these stocks, and allowing institutions to invest in US cannabis. Also opens up lower-cost debt options...
b) Waiving IRS Tax Code 280E. Because cannabis is considered a Schedule 1 Controlled Substance, operators cannot deduct SG&A expenses from their pre-tax income for tax purposes. It means US cannabis companies are paying effective tax rates of 50%+ in some instances...
8)

c) "Operational improvements" such as allowing consumers to use credit cards at dispensaries (revenue driver) and allowing US operators to streamline their banking operations (margin driver)...
9) In addition to SAFE Banking, there is a lot of talk about Congress decriminalizing or legalizing cannabis at the Federal level. Both will likely reduce penalties for small possession of cannabis and introduce several social justice initiatives, with the key difference being...
10) ...decriminalization will push the power of legalization down to the states while Federal legalization would make cannabis legal across the US. Legalization would also open the door for broad inter-state commerce while a decriminalization bill may not necessarily do so...
11) The Risks:

a) Broader market concerns
b) Regulatory changes that hurt existing operators. Possibilities include high taxation, changes to vertical integration rules, and potentially interstate commerce
c) Competition (longer-term). The brand vs. retail debate to continue...
12) It's been said before but I'll say it again: the US multi-state operators (MSOs) - and not the Canadian players -are the most direct beneficiaries of the trends outlined above...
13) I expect the top 10 US MSOs to grow sales at a 50%+ CAGR off of their run-rate 2020 sales for the next 2 years. Half of these companies operate with 30%+ EBITDA margins today and all 10 should be at that level by 2022...
14) Despite this strong growth and margin profile, the group trades at only 24x and 14x 21/22 EBITDA. There is room for multiples to expand as cannabis is a consumer staple still in its early innings of growth.

Lastly,

A few companies to follow:...
15) $AYRWF. Growing at 100%+ CAGR from 20-22 (organic is 40-50%), 40%+ EBITDA margins, trading at 6.6x 22 EBITDA. 7 state footprint incl NV, MA, FL, and PA with pending acquisitions in AZ, OH, and NJ. ~20% insider ownership. Best risk/reward in US cannabis IMO...
16) $GTBIF. Regarded as the "highest quality" US MSO. 12 state footprint with a strong presence in IL, PA, NV, OH, NJ and NY. Low-30% organic growth with mid-30% EBITDA margins trading 25x/18x 21/22 EBITDA. Could be first MSO to up-list...
17) $VRNOF. Just went public and under the radar. Their operational metrics suggest they are of same quality (maybe better) than $GTBIF. IL, FL, PA, AZ, NJ, MD. 75%+ sales CAGR over next 2 years w/ 40%+ EBITDA margins. 15.6x/10.5x 21/22 EBITDA. Trading at a big discount...
18) $TCNNF. Mostly a FL operator but with ~50% market share in the state. FL asset generates a lot of cash that the company is using to expand into other states (PA, MA). mid-30s sales CAGR, 45%+ EBITDA margins. Trading 15x/12x 21/22 EBITDA...
19) $CRLBF. Company has retail operations but focused on brands and wholesale. IL, PA, CA, MA, OH, MI, and NY. Mid-30s growth and EBITDA margins. Trading 19x/13x 21/22 EBITDA...
20) $CURLF. Largest operator in the US by footprint (23 states) and sales. $CURLF's strategy is to create the first nationwide brand in cannabis. 50% CAGR, low-20s EBITDA margin improving to low 30s. 24.5x/14.5x 21/22 EBITDA...

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Sayshu Medicherla

Sayshu Medicherla Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Sayshu_MM

1 Oct
This morning, $TCNNF completed its acquisition of $HRVSF. A big moment for the company, and congrats to @rivers_kim and team for closing the deal in under 5 months. Some highlights and thoughts from their call this morning:

...
1. PF company is the largest and most profitable MSO (by a small amount on revenue and by a meaningful amount on Adj. EBITDA)
2. PF Company has 149 stores (37% more than nearest comp) and 3.1mm sq. ft. of cultivation (~2mm is in FL)
3. Core markets: FL, AZ, PA
...
4. The biggest new (and positive) thing on the call was that the PA regulator did not require any divestitures. The PF company will have 15/16 open stores in PA with the opportunity to have up to 21 stores. They will also hold 3 cultivation licenses
...
Read 12 tweets
10 May
Merger Monday! Quick thoughts on $TCNNF / $HRVSF deal:

1. Announced price of $4.79 implies ~$2.1bn equity value and $2.25Bn EV for $HRVSF.
2. Multiples matter in M&A. $TCNNF was trading at 10.5x 22 EBITDA and is buying $HRVSF for 15.5x 22 EBITDA...
3. Its reasonable to ask if $TCNNF overpaid for $HRVSF, but also easy to understand why it is strategic. Combined entity has instant scale in FL, AZ, and PA, and gives $TCNNF something to work with in several other states...
4. Lot of questions this morning on regulatory process and caps. $TCNNF said they think there is a path to preserve value in what they bought, which I interpret to mean that if they have to divest assets/licenses they will be able to recoup value. Really only matters in PA...
Read 13 tweets
8 Apr
$VRNOF Earnings - My Takeaways:

1. Strong headline numbers on their first ever qtrly report. Total revs in 2020 up ~200% on PF basis and +247% for Verano standalone and +134% for AltMed (FL) standalone. Mostly organic per my understanding
...
2. Margins were very impressive. 63% PF GMs and 48% PF EBITDA margins. Looks like Verano standalone EM was 45% and AltMed was 53.5% in 2020. These are $TCNNF level margins with a more diversified footprint. EBITDA recon. looked fairly clean to me. There were some ??s on that...
3. Core states: IL, FL, AZ, NJ, PA, OH, MD. Company executing on capacity expansions in most of these states and deepening retail footprint throughout. Recent M&A and commentary suggests they aren't done in AZ and PA. I anticipate they will acquire cultivation in PA before YE
...
Read 12 tweets
23 Mar
$TCNNF Earnings - My Takeaways:

1. Solid beat on revs and EBITDA
2. Now selling 1 ton of weed/week(!)
3. Dominant position in FL = v strong financial metrics. 2020: 74% GM, 48% EBITDA margin, GAAP EPS of $0.53, CFO positive. Can't be overstated how strong these metrics are
...
4. In particular, I'm impressed by the magnitude of GAAP EPS. The company generated GAAP profits (and ~$100M of CFO) AFTER paying a 60% effective tax rate in 2020. Folks got excited about $GTBIF's GAAP profitability last week - $TCNNF easily beating that bar
...
5. We should expect some margin dilution over the next 24 months as the company ramps operations outside of FL. Unlikely $TCNNF will be able to achieve such high margins outside of FL so expect blended margins to mix down (not a negative, just math)
...
Read 8 tweets
18 Mar
$GTBIF Earnings - My Takeaways:

1. Strong beat across the board. 4Q revs/EBITDA up 2.3x/4.7x yoy, mostly organic. 37% EBITDA margin. Positive on a GAAP net income basis for 2nd straight qtr. 4th straight qtr of positive cash from ops. Execution continues to be v. strong.
...
2. 54 disp open rn; looking to hit the cap where they can. Driving deep into their core markets
3. CPG mix continues to increase on a net basis from 26% in 1Q to 32% in 4Q.
4. Sounds like they pulled forward a little revenue in 4Q from 1Q21
...
5. Company invested $110-120M of capex in 2020. "Will go bigger" in 2021
6. Company doesn't think AZ is as attractive as their other markets. I recently heard @Bkov9 say something similar about FL. Interesting given other MSOs are aggressively investing in these two states
...
Read 7 tweets
16 Mar
$CCHWF Earnings - My Takeaways:

1. Strong quarter, with highest qtrly EBITDA ever. Key part of the "improving profitability" story
2. Top markets in 4Q: CO, MA, PA, OH, IL
3. CA and FL should be big drivers in 2021
...
4. On CA, company is a real believer in the market (unlike most of the MSOs). CC looking to build regional density and scale accordingly. Company also looking to be a major wholesale player
...
5. On FL, $CCHWF believes it will be one of their best markets. Company working hard here including launching edibles (2021) and driving operational efficiencies. Sees a lot of "white space" in FL, which I see as a positive readthrough for $TCNNF (and others)
...
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(